Clinical Trials Logo

Clinical Trial Summary

This is a first in human, open-label, exploratory phase I clinical study including dose escalation (Ia) and dose expansion (Ib) stage. It aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BC006 in giant cell tumor of tendon sheath (GCTTS) and other advanced solid tumors.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05212896
Study type Interventional
Source Dragonboat Biopharmaceutical Company Limited
Contact Yuan Peng
Phone #86#021-50276381
Status Recruiting
Phase Phase 1
Start date November 26, 2021
Completion date December 2024